nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—esophageal cancer	0.424	1	CbGaD
Morphine—UGT2B4—pericardium—esophageal cancer	0.0403	0.571	CbGeAlD
Morphine—UGT1A8—digestive system—esophageal cancer	0.00524	0.0744	CbGeAlD
Morphine—UGT1A3—digestive system—esophageal cancer	0.00467	0.0663	CbGeAlD
Morphine—UGT2B15—digestive system—esophageal cancer	0.0044	0.0623	CbGeAlD
Morphine—Naloxone—TLR4—esophageal cancer	0.00435	0.655	CrCbGaD
Morphine—UGT2B4—lung—esophageal cancer	0.00407	0.0577	CbGeAlD
Morphine—OPRL1—lymph node—esophageal cancer	0.00292	0.0414	CbGeAlD
Morphine—UGT2B7—digestive system—esophageal cancer	0.00268	0.0381	CbGeAlD
Morphine—UGT1A1—digestive system—esophageal cancer	0.00228	0.0324	CbGeAlD
Morphine—Hydromorphone—PTGS1—esophageal cancer	0.00106	0.16	CrCbGaD
Morphine—Eye pain—Capecitabine—esophageal cancer	0.000771	0.0035	CcSEcCtD
Morphine—Dysarthria—Methotrexate—esophageal cancer	0.000755	0.00343	CcSEcCtD
Morphine—Ulcer—Methotrexate—esophageal cancer	0.000755	0.00343	CcSEcCtD
Morphine—Libido decreased—Capecitabine—esophageal cancer	0.000751	0.00341	CcSEcCtD
Morphine—Amnesia—Capecitabine—esophageal cancer	0.000741	0.00336	CcSEcCtD
Morphine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000735	0.00334	CcSEcCtD
Morphine—CYP3A4—digestive system—esophageal cancer	0.000732	0.0104	CbGeAlD
Morphine—Renal impairment—Capecitabine—esophageal cancer	0.000731	0.00332	CcSEcCtD
Morphine—Thirst—Capecitabine—esophageal cancer	0.000731	0.00332	CcSEcCtD
Morphine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000728	0.00331	CcSEcCtD
Morphine—Respiratory failure—Methotrexate—esophageal cancer	0.000727	0.0033	CcSEcCtD
Morphine—CYP2D6—digestive system—esophageal cancer	0.00072	0.0102	CbGeAlD
Morphine—Renal failure—Cisplatin—esophageal cancer	0.000715	0.00325	CcSEcCtD
Morphine—Pulmonary embolism—Methotrexate—esophageal cancer	0.000714	0.00324	CcSEcCtD
Morphine—Naltrexone—ABCB1—esophageal cancer	0.000711	0.107	CrCbGaD
Morphine—Lethargy—Capecitabine—esophageal cancer	0.00071	0.00323	CcSEcCtD
Morphine—Stomatitis—Cisplatin—esophageal cancer	0.000709	0.00322	CcSEcCtD
Morphine—Conjunctivitis—Cisplatin—esophageal cancer	0.000707	0.00321	CcSEcCtD
Morphine—Hyponatraemia—Capecitabine—esophageal cancer	0.000699	0.00317	CcSEcCtD
Morphine—Osteoarthritis—Capecitabine—esophageal cancer	0.000696	0.00316	CcSEcCtD
Morphine—Diplopia—Capecitabine—esophageal cancer	0.000696	0.00316	CcSEcCtD
Morphine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000691	0.00314	CcSEcCtD
Morphine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000689	0.00313	CcSEcCtD
Morphine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000688	0.00313	CcSEcCtD
Morphine—ABCB1—epithelium—esophageal cancer	0.000681	0.00965	CbGeAlD
Morphine—Bradycardia—Cisplatin—esophageal cancer	0.000665	0.00302	CcSEcCtD
Morphine—Cardiac arrest—Capecitabine—esophageal cancer	0.000662	0.00301	CcSEcCtD
Morphine—Urinary retention—Capecitabine—esophageal cancer	0.000662	0.00301	CcSEcCtD
Morphine—Mood swings—Capecitabine—esophageal cancer	0.000659	0.00299	CcSEcCtD
Morphine—Ataxia—Capecitabine—esophageal cancer	0.000655	0.00297	CcSEcCtD
Morphine—Coma—Methotrexate—esophageal cancer	0.000652	0.00296	CcSEcCtD
Morphine—Dehydration—Capecitabine—esophageal cancer	0.000647	0.00294	CcSEcCtD
Morphine—Bladder pain—Methotrexate—esophageal cancer	0.000645	0.00293	CcSEcCtD
Morphine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000645	0.00293	CcSEcCtD
Morphine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000643	0.00292	CcSEcCtD
Morphine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000642	0.00292	CcSEcCtD
Morphine—Urethral disorder—Cisplatin—esophageal cancer	0.00064	0.00291	CcSEcCtD
Morphine—Gynaecomastia—Methotrexate—esophageal cancer	0.000639	0.0029	CcSEcCtD
Morphine—Dry skin—Capecitabine—esophageal cancer	0.000638	0.0029	CcSEcCtD
Morphine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000636	0.00289	CcSEcCtD
Morphine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000636	0.00289	CcSEcCtD
Morphine—Pulmonary oedema—Methotrexate—esophageal cancer	0.000635	0.00289	CcSEcCtD
Morphine—Hypokalaemia—Capecitabine—esophageal cancer	0.000633	0.00288	CcSEcCtD
Morphine—Visual impairment—Cisplatin—esophageal cancer	0.00063	0.00286	CcSEcCtD
Morphine—Breast disorder—Capecitabine—esophageal cancer	0.000629	0.00286	CcSEcCtD
Morphine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000622	0.00283	CcSEcCtD
Morphine—Sepsis—Methotrexate—esophageal cancer	0.000619	0.00281	CcSEcCtD
Morphine—Eye disorder—Cisplatin—esophageal cancer	0.00061	0.00277	CcSEcCtD
Morphine—Flushing—Cisplatin—esophageal cancer	0.000606	0.00275	CcSEcCtD
Morphine—Abdominal distension—Capecitabine—esophageal cancer	0.000606	0.00275	CcSEcCtD
Morphine—ABCB1—trachea—esophageal cancer	0.000602	0.00854	CbGeAlD
Morphine—Influenza—Capecitabine—esophageal cancer	0.000602	0.00273	CcSEcCtD
Morphine—Dysphagia—Capecitabine—esophageal cancer	0.000602	0.00273	CcSEcCtD
Morphine—Bronchospasm—Capecitabine—esophageal cancer	0.000592	0.00269	CcSEcCtD
Morphine—Polyuria—Methotrexate—esophageal cancer	0.00059	0.00268	CcSEcCtD
Morphine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000589	0.00267	CcSEcCtD
Morphine—Sweating increased—Capecitabine—esophageal cancer	0.000586	0.00266	CcSEcCtD
Morphine—Erythema—Cisplatin—esophageal cancer	0.000569	0.00258	CcSEcCtD
Morphine—Malnutrition—Cisplatin—esophageal cancer	0.000569	0.00258	CcSEcCtD
Morphine—Dysuria—Capecitabine—esophageal cancer	0.000563	0.00255	CcSEcCtD
Morphine—Flatulence—Cisplatin—esophageal cancer	0.00056	0.00254	CcSEcCtD
Morphine—Visual disturbance—Methotrexate—esophageal cancer	0.000547	0.00248	CcSEcCtD
Morphine—Muscle spasms—Cisplatin—esophageal cancer	0.000547	0.00248	CcSEcCtD
Morphine—Weight decreased—Capecitabine—esophageal cancer	0.000544	0.00247	CcSEcCtD
Morphine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000543	0.00246	CcSEcCtD
Morphine—Vision blurred—Cisplatin—esophageal cancer	0.000536	0.00243	CcSEcCtD
Morphine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000535	0.00243	CcSEcCtD
Morphine—Tremor—Cisplatin—esophageal cancer	0.000533	0.00242	CcSEcCtD
Morphine—Lethargy—Methotrexate—esophageal cancer	0.000529	0.0024	CcSEcCtD
Morphine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000528	0.0024	CcSEcCtD
Morphine—Renal failure—Capecitabine—esophageal cancer	0.000527	0.00239	CcSEcCtD
Morphine—Anaemia—Cisplatin—esophageal cancer	0.000526	0.00239	CcSEcCtD
Morphine—Stomatitis—Capecitabine—esophageal cancer	0.000523	0.00237	CcSEcCtD
Morphine—Urinary tract infection—Capecitabine—esophageal cancer	0.000521	0.00237	CcSEcCtD
Morphine—Conjunctivitis—Capecitabine—esophageal cancer	0.000521	0.00237	CcSEcCtD
Morphine—Naloxone—ABCB1—esophageal cancer	0.000518	0.0781	CrCbGaD
Morphine—Osteoarthritis—Methotrexate—esophageal cancer	0.000518	0.00235	CcSEcCtD
Morphine—ABCB1—digestive system—esophageal cancer	0.000518	0.00734	CbGeAlD
Morphine—Malaise—Cisplatin—esophageal cancer	0.000513	0.00233	CcSEcCtD
Morphine—Leukopenia—Cisplatin—esophageal cancer	0.000509	0.00231	CcSEcCtD
Morphine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000507	0.0023	CcSEcCtD
Morphine—Convulsion—Cisplatin—esophageal cancer	0.000493	0.00224	CcSEcCtD
Morphine—Mood swings—Methotrexate—esophageal cancer	0.000491	0.00223	CcSEcCtD
Morphine—Bradycardia—Capecitabine—esophageal cancer	0.00049	0.00223	CcSEcCtD
Morphine—Ataxia—Methotrexate—esophageal cancer	0.000487	0.00221	CcSEcCtD
Morphine—Rhinitis—Capecitabine—esophageal cancer	0.000483	0.00219	CcSEcCtD
Morphine—Anxiety—Cisplatin—esophageal cancer	0.000482	0.00219	CcSEcCtD
Morphine—Hepatitis—Capecitabine—esophageal cancer	0.000482	0.00219	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000481	0.00218	CcSEcCtD
Morphine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000479	0.00218	CcSEcCtD
Morphine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000478	0.00217	CcSEcCtD
Morphine—Discomfort—Cisplatin—esophageal cancer	0.000478	0.00217	CcSEcCtD
Morphine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000476	0.00216	CcSEcCtD
Morphine—Oedema peripheral—Capecitabine—esophageal cancer	0.000474	0.00215	CcSEcCtD
Morphine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000473	0.00215	CcSEcCtD
Morphine—Urethral disorder—Capecitabine—esophageal cancer	0.000472	0.00214	CcSEcCtD
Morphine—Breast disorder—Methotrexate—esophageal cancer	0.000468	0.00213	CcSEcCtD
Morphine—Oedema—Cisplatin—esophageal cancer	0.000464	0.00211	CcSEcCtD
Morphine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000464	0.00211	CcSEcCtD
Morphine—Visual impairment—Capecitabine—esophageal cancer	0.000464	0.00211	CcSEcCtD
Morphine—Infection—Cisplatin—esophageal cancer	0.000461	0.00209	CcSEcCtD
Morphine—Nervous system disorder—Cisplatin—esophageal cancer	0.000455	0.00207	CcSEcCtD
Morphine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000454	0.00206	CcSEcCtD
Morphine—Tachycardia—Cisplatin—esophageal cancer	0.000453	0.00206	CcSEcCtD
Morphine—Skin disorder—Cisplatin—esophageal cancer	0.000451	0.00205	CcSEcCtD
Morphine—Eye disorder—Capecitabine—esophageal cancer	0.00045	0.00204	CcSEcCtD
Morphine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000449	0.00204	CcSEcCtD
Morphine—Flushing—Capecitabine—esophageal cancer	0.000447	0.00203	CcSEcCtD
Morphine—Eosinophilia—Methotrexate—esophageal cancer	0.000443	0.00201	CcSEcCtD
Morphine—Anorexia—Cisplatin—esophageal cancer	0.000442	0.00201	CcSEcCtD
Morphine—Angiopathy—Capecitabine—esophageal cancer	0.000437	0.00198	CcSEcCtD
Morphine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000434	0.00197	CcSEcCtD
Morphine—Hypotension—Cisplatin—esophageal cancer	0.000434	0.00197	CcSEcCtD
Morphine—ABCB1—lung—esophageal cancer	0.000433	0.00613	CbGeAlD
Morphine—Chills—Capecitabine—esophageal cancer	0.000432	0.00196	CcSEcCtD
Morphine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000423	0.00192	CcSEcCtD
Morphine—Mental disorder—Capecitabine—esophageal cancer	0.000422	0.00192	CcSEcCtD
Morphine—Malnutrition—Capecitabine—esophageal cancer	0.000419	0.0019	CcSEcCtD
Morphine—Erythema—Capecitabine—esophageal cancer	0.000419	0.0019	CcSEcCtD
Morphine—Dysuria—Methotrexate—esophageal cancer	0.000419	0.0019	CcSEcCtD
Morphine—Paraesthesia—Cisplatin—esophageal cancer	0.000417	0.00189	CcSEcCtD
Morphine—Dyspnoea—Cisplatin—esophageal cancer	0.000414	0.00188	CcSEcCtD
Morphine—Flatulence—Capecitabine—esophageal cancer	0.000413	0.00188	CcSEcCtD
Morphine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000412	0.00187	CcSEcCtD
Morphine—Dysgeusia—Capecitabine—esophageal cancer	0.000411	0.00186	CcSEcCtD
Morphine—Back pain—Capecitabine—esophageal cancer	0.000405	0.00184	CcSEcCtD
Morphine—Decreased appetite—Cisplatin—esophageal cancer	0.000403	0.00183	CcSEcCtD
Morphine—Muscle spasms—Capecitabine—esophageal cancer	0.000403	0.00183	CcSEcCtD
Morphine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000401	0.00182	CcSEcCtD
Morphine—Drowsiness—Methotrexate—esophageal cancer	0.000399	0.00181	CcSEcCtD
Morphine—Pain—Cisplatin—esophageal cancer	0.000397	0.0018	CcSEcCtD
Morphine—Vision blurred—Capecitabine—esophageal cancer	0.000395	0.00179	CcSEcCtD
Morphine—Tremor—Capecitabine—esophageal cancer	0.000393	0.00178	CcSEcCtD
Morphine—Renal failure—Methotrexate—esophageal cancer	0.000393	0.00178	CcSEcCtD
Morphine—Stomatitis—Methotrexate—esophageal cancer	0.000389	0.00177	CcSEcCtD
Morphine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000389	0.00177	CcSEcCtD
Morphine—Conjunctivitis—Methotrexate—esophageal cancer	0.000388	0.00176	CcSEcCtD
Morphine—Anaemia—Capecitabine—esophageal cancer	0.000387	0.00176	CcSEcCtD
Morphine—Sweating—Methotrexate—esophageal cancer	0.000383	0.00174	CcSEcCtD
Morphine—Feeling abnormal—Cisplatin—esophageal cancer	0.000382	0.00174	CcSEcCtD
Morphine—Malaise—Capecitabine—esophageal cancer	0.000378	0.00172	CcSEcCtD
Morphine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000378	0.00172	CcSEcCtD
Morphine—Vertigo—Capecitabine—esophageal cancer	0.000377	0.00171	CcSEcCtD
Morphine—Syncope—Capecitabine—esophageal cancer	0.000376	0.00171	CcSEcCtD
Morphine—Leukopenia—Capecitabine—esophageal cancer	0.000375	0.0017	CcSEcCtD
Morphine—Palpitations—Capecitabine—esophageal cancer	0.00037	0.00168	CcSEcCtD
Morphine—Loss of consciousness—Capecitabine—esophageal cancer	0.000368	0.00167	CcSEcCtD
Morphine—Body temperature increased—Cisplatin—esophageal cancer	0.000367	0.00167	CcSEcCtD
Morphine—Cough—Capecitabine—esophageal cancer	0.000366	0.00166	CcSEcCtD
Morphine—Hypertension—Capecitabine—esophageal cancer	0.000362	0.00164	CcSEcCtD
Morphine—Hepatitis—Methotrexate—esophageal cancer	0.000358	0.00163	CcSEcCtD
Morphine—Arthralgia—Capecitabine—esophageal cancer	0.000357	0.00162	CcSEcCtD
Morphine—Chest pain—Capecitabine—esophageal cancer	0.000357	0.00162	CcSEcCtD
Morphine—Anxiety—Capecitabine—esophageal cancer	0.000356	0.00162	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000354	0.00161	CcSEcCtD
Morphine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000354	0.00161	CcSEcCtD
Morphine—Discomfort—Capecitabine—esophageal cancer	0.000353	0.0016	CcSEcCtD
Morphine—Urethral disorder—Methotrexate—esophageal cancer	0.000351	0.0016	CcSEcCtD
Morphine—Dry mouth—Capecitabine—esophageal cancer	0.000349	0.00159	CcSEcCtD
Morphine—Visual impairment—Methotrexate—esophageal cancer	0.000345	0.00157	CcSEcCtD
Morphine—Confusional state—Capecitabine—esophageal cancer	0.000345	0.00157	CcSEcCtD
Morphine—Oedema—Capecitabine—esophageal cancer	0.000342	0.00155	CcSEcCtD
Morphine—Hypersensitivity—Cisplatin—esophageal cancer	0.000342	0.00155	CcSEcCtD
Morphine—Infection—Capecitabine—esophageal cancer	0.00034	0.00154	CcSEcCtD
Morphine—Shock—Capecitabine—esophageal cancer	0.000337	0.00153	CcSEcCtD
Morphine—Nervous system disorder—Capecitabine—esophageal cancer	0.000336	0.00152	CcSEcCtD
Morphine—Eye disorder—Methotrexate—esophageal cancer	0.000335	0.00152	CcSEcCtD
Morphine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000335	0.00152	CcSEcCtD
Morphine—Tachycardia—Capecitabine—esophageal cancer	0.000334	0.00152	CcSEcCtD
Morphine—Asthenia—Cisplatin—esophageal cancer	0.000333	0.00151	CcSEcCtD
Morphine—Skin disorder—Capecitabine—esophageal cancer	0.000332	0.00151	CcSEcCtD
Morphine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000331	0.0015	CcSEcCtD
Morphine—Anorexia—Capecitabine—esophageal cancer	0.000326	0.00148	CcSEcCtD
Morphine—Angiopathy—Methotrexate—esophageal cancer	0.000325	0.00148	CcSEcCtD
Morphine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000323	0.00147	CcSEcCtD
Morphine—Chills—Methotrexate—esophageal cancer	0.000322	0.00146	CcSEcCtD
Morphine—Hypotension—Capecitabine—esophageal cancer	0.00032	0.00145	CcSEcCtD
Morphine—Diarrhoea—Cisplatin—esophageal cancer	0.000318	0.00144	CcSEcCtD
Morphine—Mental disorder—Methotrexate—esophageal cancer	0.000314	0.00143	CcSEcCtD
Morphine—Erythema—Methotrexate—esophageal cancer	0.000312	0.00142	CcSEcCtD
Morphine—Malnutrition—Methotrexate—esophageal cancer	0.000312	0.00142	CcSEcCtD
Morphine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000312	0.00142	CcSEcCtD
Morphine—Insomnia—Capecitabine—esophageal cancer	0.000309	0.00141	CcSEcCtD
Morphine—Paraesthesia—Capecitabine—esophageal cancer	0.000307	0.0014	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—esophageal cancer	0.000306	0.00139	CcSEcCtD
Morphine—Dyspnoea—Capecitabine—esophageal cancer	0.000305	0.00139	CcSEcCtD
Morphine—Back pain—Methotrexate—esophageal cancer	0.000302	0.00137	CcSEcCtD
Morphine—Dyspepsia—Capecitabine—esophageal cancer	0.000301	0.00137	CcSEcCtD
Morphine—Decreased appetite—Capecitabine—esophageal cancer	0.000297	0.00135	CcSEcCtD
Morphine—ABCB1—lymph node—esophageal cancer	0.000296	0.00419	CbGeAlD
Morphine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000295	0.00134	CcSEcCtD
Morphine—Vomiting—Cisplatin—esophageal cancer	0.000295	0.00134	CcSEcCtD
Morphine—Fatigue—Capecitabine—esophageal cancer	0.000295	0.00134	CcSEcCtD
Morphine—Vision blurred—Methotrexate—esophageal cancer	0.000294	0.00134	CcSEcCtD
Morphine—Rash—Cisplatin—esophageal cancer	0.000293	0.00133	CcSEcCtD
Morphine—Pain—Capecitabine—esophageal cancer	0.000293	0.00133	CcSEcCtD
Morphine—Constipation—Capecitabine—esophageal cancer	0.000293	0.00133	CcSEcCtD
Morphine—Dermatitis—Cisplatin—esophageal cancer	0.000292	0.00133	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00029	0.00131	CcSEcCtD
Morphine—Anaemia—Methotrexate—esophageal cancer	0.000288	0.00131	CcSEcCtD
Morphine—Feeling abnormal—Capecitabine—esophageal cancer	0.000282	0.00128	CcSEcCtD
Morphine—Malaise—Methotrexate—esophageal cancer	0.000281	0.00128	CcSEcCtD
Morphine—Vertigo—Methotrexate—esophageal cancer	0.00028	0.00127	CcSEcCtD
Morphine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00028	0.00127	CcSEcCtD
Morphine—Leukopenia—Methotrexate—esophageal cancer	0.000279	0.00127	CcSEcCtD
Morphine—Nausea—Cisplatin—esophageal cancer	0.000276	0.00125	CcSEcCtD
Morphine—Cough—Methotrexate—esophageal cancer	0.000272	0.00124	CcSEcCtD
Morphine—Urticaria—Capecitabine—esophageal cancer	0.000272	0.00123	CcSEcCtD
Morphine—Abdominal pain—Capecitabine—esophageal cancer	0.00027	0.00123	CcSEcCtD
Morphine—Body temperature increased—Capecitabine—esophageal cancer	0.00027	0.00123	CcSEcCtD
Morphine—Convulsion—Methotrexate—esophageal cancer	0.00027	0.00123	CcSEcCtD
Morphine—Chest pain—Methotrexate—esophageal cancer	0.000266	0.00121	CcSEcCtD
Morphine—Arthralgia—Methotrexate—esophageal cancer	0.000266	0.00121	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000264	0.0012	CcSEcCtD
Morphine—Discomfort—Methotrexate—esophageal cancer	0.000262	0.00119	CcSEcCtD
Morphine—Confusional state—Methotrexate—esophageal cancer	0.000257	0.00117	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000255	0.00116	CcSEcCtD
Morphine—Infection—Methotrexate—esophageal cancer	0.000253	0.00115	CcSEcCtD
Morphine—Hypersensitivity—Capecitabine—esophageal cancer	0.000252	0.00114	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—esophageal cancer	0.00025	0.00113	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000249	0.00113	CcSEcCtD
Morphine—Skin disorder—Methotrexate—esophageal cancer	0.000247	0.00112	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000246	0.00112	CcSEcCtD
Morphine—Asthenia—Capecitabine—esophageal cancer	0.000245	0.00111	CcSEcCtD
Morphine—Anorexia—Methotrexate—esophageal cancer	0.000243	0.0011	CcSEcCtD
Morphine—Pruritus—Capecitabine—esophageal cancer	0.000242	0.0011	CcSEcCtD
Morphine—Hypotension—Methotrexate—esophageal cancer	0.000238	0.00108	CcSEcCtD
Morphine—Diarrhoea—Capecitabine—esophageal cancer	0.000234	0.00106	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000232	0.00105	CcSEcCtD
Morphine—Insomnia—Methotrexate—esophageal cancer	0.00023	0.00105	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—esophageal cancer	0.000229	0.00104	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—esophageal cancer	0.000227	0.00103	CcSEcCtD
Morphine—Somnolence—Methotrexate—esophageal cancer	0.000226	0.00103	CcSEcCtD
Morphine—Dizziness—Capecitabine—esophageal cancer	0.000226	0.00103	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—esophageal cancer	0.000224	0.00102	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—esophageal cancer	0.000221	0.00101	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00022	0.000999	CcSEcCtD
Morphine—Fatigue—Methotrexate—esophageal cancer	0.00022	0.000997	CcSEcCtD
Morphine—Pain—Methotrexate—esophageal cancer	0.000218	0.000989	CcSEcCtD
Morphine—Vomiting—Capecitabine—esophageal cancer	0.000218	0.000988	CcSEcCtD
Morphine—Rash—Capecitabine—esophageal cancer	0.000216	0.00098	CcSEcCtD
Morphine—Dermatitis—Capecitabine—esophageal cancer	0.000216	0.000979	CcSEcCtD
Morphine—Headache—Capecitabine—esophageal cancer	0.000214	0.000973	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—esophageal cancer	0.00021	0.000953	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000208	0.000946	CcSEcCtD
Morphine—Nausea—Capecitabine—esophageal cancer	0.000203	0.000923	CcSEcCtD
Morphine—Urticaria—Methotrexate—esophageal cancer	0.000202	0.000919	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—esophageal cancer	0.000201	0.000914	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—esophageal cancer	0.000201	0.000914	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—esophageal cancer	0.000188	0.000852	CcSEcCtD
Morphine—Asthenia—Methotrexate—esophageal cancer	0.000183	0.00083	CcSEcCtD
Morphine—Pruritus—Methotrexate—esophageal cancer	0.00018	0.000818	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—esophageal cancer	0.000174	0.000791	CcSEcCtD
Morphine—Dizziness—Methotrexate—esophageal cancer	0.000168	0.000765	CcSEcCtD
Morphine—Vomiting—Methotrexate—esophageal cancer	0.000162	0.000735	CcSEcCtD
Morphine—Rash—Methotrexate—esophageal cancer	0.000161	0.000729	CcSEcCtD
Morphine—Dermatitis—Methotrexate—esophageal cancer	0.00016	0.000729	CcSEcCtD
Morphine—Headache—Methotrexate—esophageal cancer	0.00016	0.000725	CcSEcCtD
Morphine—Nausea—Methotrexate—esophageal cancer	0.000151	0.000687	CcSEcCtD
Morphine—UGT1A1—Metabolism—PSME2—esophageal cancer	4.28e-05	0.000154	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PSME1—esophageal cancer	4.28e-05	0.000154	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—EP300—esophageal cancer	4.28e-05	0.000154	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP19A1—esophageal cancer	4.27e-05	0.000153	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CA1—esophageal cancer	4.25e-05	0.000153	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.25e-05	0.000153	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GNG7—esophageal cancer	4.25e-05	0.000153	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.2e-05	0.000151	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PLCE1—esophageal cancer	4.15e-05	0.000149	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ADH7—esophageal cancer	4.15e-05	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PSME2—esophageal cancer	4.14e-05	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PSME1—esophageal cancer	4.14e-05	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	4.12e-05	0.000148	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.1e-05	0.000147	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.1e-05	0.000147	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CA1—esophageal cancer	4.01e-05	0.000144	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	4.01e-05	0.000144	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SST—esophageal cancer	4.01e-05	0.000144	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	4e-05	0.000144	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—XIAP—esophageal cancer	3.98e-05	0.000143	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	3.91e-05	0.00014	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GHRL—esophageal cancer	3.91e-05	0.00014	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—HMOX1—esophageal cancer	3.9e-05	0.00014	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CA2—esophageal cancer	3.89e-05	0.00014	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCND1—esophageal cancer	3.89e-05	0.00014	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	3.84e-05	0.000138	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	3.77e-05	0.000135	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CDKN1A—esophageal cancer	3.76e-05	0.000135	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	3.75e-05	0.000135	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ABCB1—esophageal cancer	3.74e-05	0.000134	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—EP300—esophageal cancer	3.74e-05	0.000134	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—EP300—esophageal cancer	3.74e-05	0.000134	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.71e-05	0.000133	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP1B1—esophageal cancer	3.69e-05	0.000133	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CA2—esophageal cancer	3.67e-05	0.000132	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ADH1B—esophageal cancer	3.64e-05	0.000131	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PLCE1—esophageal cancer	3.62e-05	0.00013	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ADH7—esophageal cancer	3.62e-05	0.00013	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.59e-05	0.000129	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EP300—esophageal cancer	3.58e-05	0.000129	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	3.54e-05	0.000127	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	3.5e-05	0.000126	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PSME2—esophageal cancer	3.5e-05	0.000126	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PSME1—esophageal cancer	3.5e-05	0.000126	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	3.48e-05	0.000125	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMP—esophageal cancer	3.48e-05	0.000125	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP19A1—esophageal cancer	3.47e-05	0.000125	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.41e-05	0.000123	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.41e-05	0.000122	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ADH7—esophageal cancer	3.41e-05	0.000122	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SST—esophageal cancer	3.39e-05	0.000122	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.39e-05	0.000122	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	3.35e-05	0.000121	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	3.3e-05	0.000119	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GHRL—esophageal cancer	3.3e-05	0.000119	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALOX15—esophageal cancer	3.3e-05	0.000119	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	3.25e-05	0.000117	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ADH1B—esophageal cancer	3.17e-05	0.000114	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—HMOX1—esophageal cancer	3.17e-05	0.000114	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PIK3CA—esophageal cancer	3.16e-05	0.000114	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TPI1—esophageal cancer	3.15e-05	0.000113	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.15e-05	0.000113	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MYC—esophageal cancer	3.12e-05	0.000112	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	3.11e-05	0.000112	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.1e-05	0.000111	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.08e-05	0.000111	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.08e-05	0.000111	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—esophageal cancer	3.05e-05	0.00011	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ABCB1—esophageal cancer	3.04e-05	0.000109	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMP—esophageal cancer	3.03e-05	0.000109	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.02e-05	0.000108	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.99e-05	0.000107	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.98e-05	0.000107	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	2.96e-05	0.000106	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.95e-05	0.000106	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	2.94e-05	0.000106	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CREBBP—esophageal cancer	2.94e-05	0.000106	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.91e-05	0.000105	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.9e-05	0.000104	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.88e-05	0.000103	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALOX15—esophageal cancer	2.87e-05	0.000103	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMP—esophageal cancer	2.86e-05	0.000103	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.78e-05	9.98e-05	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—esophageal cancer	2.77e-05	9.94e-05	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—esophageal cancer	2.77e-05	9.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	2.74e-05	9.86e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TPI1—esophageal cancer	2.74e-05	9.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTO1—esophageal cancer	2.74e-05	9.85e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNG7—esophageal cancer	2.74e-05	9.84e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.71e-05	9.73e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—esophageal cancer	2.65e-05	9.51e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—NOS3—esophageal cancer	2.63e-05	9.46e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALDOB—esophageal cancer	2.63e-05	9.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	2.63e-05	9.44e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KDR—esophageal cancer	2.63e-05	9.43e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CA1—esophageal cancer	2.62e-05	9.42e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.62e-05	9.42e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TPI1—esophageal cancer	2.58e-05	9.28e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.58e-05	9.28e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.57e-05	9.22e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—esophageal cancer	2.56e-05	9.2e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GAPDH—esophageal cancer	2.53e-05	9.09e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.53e-05	9.07e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CRABP1—esophageal cancer	2.51e-05	9.01e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CREBBP—esophageal cancer	2.5e-05	8.98e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	2.49e-05	8.93e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.48e-05	8.9e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	2.47e-05	8.88e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.44e-05	8.78e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.44e-05	8.77e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.41e-05	8.67e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—esophageal cancer	2.41e-05	8.65e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	2.41e-05	8.65e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.4e-05	8.63e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CA2—esophageal cancer	2.4e-05	8.61e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNG7—esophageal cancer	2.39e-05	8.57e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.38e-05	8.57e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.36e-05	8.49e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KDR—esophageal cancer	2.3e-05	8.27e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ENO1—esophageal cancer	2.29e-05	8.21e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.29e-05	8.21e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PSME1—esophageal cancer	2.25e-05	8.09e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PSME2—esophageal cancer	2.25e-05	8.09e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNG7—esophageal cancer	2.25e-05	8.07e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	2.24e-05	8.05e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NOS3—esophageal cancer	2.24e-05	8.04e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALDH2—esophageal cancer	2.24e-05	8.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.23e-05	8.01e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ADH7—esophageal cancer	2.23e-05	8.01e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	2.2e-05	7.92e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	2.17e-05	7.79e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTT1—esophageal cancer	2.13e-05	7.64e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.11e-05	7.57e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.11e-05	7.56e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.1e-05	7.55e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—esophageal cancer	2.05e-05	7.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	2.03e-05	7.31e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CREBBP—esophageal cancer	2.03e-05	7.3e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOS3—esophageal cancer	2.01e-05	7.21e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTT1—esophageal cancer	2e-05	7.2e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—EP300—esophageal cancer	2e-05	7.2e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS1—esophageal cancer	1.99e-05	7.16e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ENO1—esophageal cancer	1.99e-05	7.16e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.99e-05	7.15e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.98e-05	7.11e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.97e-05	7.07e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	1.97e-05	7.06e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PSME1—esophageal cancer	1.96e-05	7.05e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PSME2—esophageal cancer	1.96e-05	7.05e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.95e-05	7.02e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KDR—esophageal cancer	1.95e-05	6.99e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.94e-05	6.98e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	1.93e-05	6.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	1.91e-05	6.87e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	1.88e-05	6.75e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ENO1—esophageal cancer	1.88e-05	6.74e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.88e-05	6.74e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMP—esophageal cancer	1.87e-05	6.71e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PSME1—esophageal cancer	1.85e-05	6.65e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PSME2—esophageal cancer	1.85e-05	6.65e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.85e-05	6.63e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	1.83e-05	6.58e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.83e-05	6.57e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NOS3—esophageal cancer	1.82e-05	6.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.82e-05	6.53e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.77e-05	6.36e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOS3—esophageal cancer	1.76e-05	6.32e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—esophageal cancer	1.7e-05	6.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.69e-05	6.08e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.69e-05	6.07e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.69e-05	6.07e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	1.68e-05	6.02e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.67e-05	5.99e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—esophageal cancer	1.66e-05	5.98e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	1.66e-05	5.97e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—esophageal cancer	1.66e-05	5.96e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	1.65e-05	5.92e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.64e-05	5.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	1.63e-05	5.87e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.62e-05	5.82e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.6e-05	5.77e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.6e-05	5.75e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.6e-05	5.73e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.59e-05	5.72e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.56e-05	5.61e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.56e-05	5.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.54e-05	5.55e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—esophageal cancer	1.53e-05	5.49e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.5e-05	5.39e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOS3—esophageal cancer	1.49e-05	5.34e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—esophageal cancer	1.48e-05	5.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.47e-05	5.28e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—esophageal cancer	1.45e-05	5.23e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.45e-05	5.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.42e-05	5.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	1.41e-05	5.06e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	1.39e-05	5e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—esophageal cancer	1.38e-05	4.97e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.38e-05	4.95e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.37e-05	4.92e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—esophageal cancer	1.34e-05	4.81e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—esophageal cancer	1.33e-05	4.78e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.31e-05	4.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.31e-05	4.71e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—esophageal cancer	1.3e-05	4.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.29e-05	4.65e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—esophageal cancer	1.26e-05	4.53e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—esophageal cancer	1.23e-05	4.42e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.23e-05	4.41e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.23e-05	4.41e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.21e-05	4.35e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.21e-05	4.34e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.21e-05	4.34e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.19e-05	4.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—esophageal cancer	1.17e-05	4.19e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—esophageal cancer	1.14e-05	4.1e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—esophageal cancer	1.13e-05	4.07e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	1.13e-05	4.06e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—esophageal cancer	1.09e-05	3.93e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.07e-05	3.84e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.04e-05	3.75e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—esophageal cancer	1.02e-05	3.68e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	9.91e-06	3.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—esophageal cancer	9.86e-06	3.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.81e-06	3.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—esophageal cancer	9.65e-06	3.47e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—esophageal cancer	9.58e-06	3.44e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NOS3—esophageal cancer	9.58e-06	3.44e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CREBBP—esophageal cancer	9.32e-06	3.35e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.95e-06	3.22e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CREBBP—esophageal cancer	8.78e-06	3.16e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—esophageal cancer	8.76e-06	3.15e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.59e-06	3.09e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	8.37e-06	3.01e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NOS3—esophageal cancer	8.35e-06	3e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—esophageal cancer	8.1e-06	2.91e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NOS3—esophageal cancer	7.87e-06	2.83e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—esophageal cancer	7.63e-06	2.74e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—esophageal cancer	7.29e-06	2.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—esophageal cancer	7.19e-06	2.58e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—esophageal cancer	6.35e-06	2.28e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—esophageal cancer	5.98e-06	2.15e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.74e-06	2.06e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	5.39e-06	1.94e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NOS3—esophageal cancer	5.14e-06	1.85e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.7e-06	1.69e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.7e-06	1.69e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.43e-06	1.59e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—esophageal cancer	3.91e-06	1.41e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.89e-06	1.04e-05	CbGpPWpGaD
